Molnupiravir versus. COVID-19: Has it resided to the early hype?
In the quest for effective COVID-19 treatments, many drugs unsuccessful to meet their early promise. The antiviral molnupiravir performed well in trials, reducing hospitalizations and deaths among individuals at high-risk. Medical News Today has revisited evidence and checked out new findings to determine whether molnupiravir has recognized its potential.
All data and statistics derive from openly available data during the time of publication. Some good info might be outdated. Visit our coronavirus hub and follow our live updates page which are more recent info on the COVID-19 pandemic.
In October 2021, a worldwide trial investigated an experimental viral drug known as molnupiravir, that is branded Lagevrio outdoors the U . s . States.
The study was brought through the pharmaceuti...